Small Molecule Active Targeting Nano Delivery System Preparation Platform
We use chemical modification technology to modify protein drugs to solve the problems of short half-life and immunogenicity of large molecular protein drugs in blood, maintain the drug biological activity of protein, improve the half-life of protein, which is the development trend of biotechnology drugs in recent years. The company has mastered PEG (POLYEthyleneglycol) modification and aliphatic chain modification technology of protein polypeptide drugs to achieve the technical goal of long-term effect of drugs. PEG modifiers have the advantages of non-toxicity, good solubility, low immunogenicity and diversified modification methods, and are one of the few synthetic polymers approved by FDA that can be used for in vivo injection. The key core is that the company's PROTEIN PEG modification technology has the ability to achieve site-specific modifications, as opposed to random modifications currently available on the market, resulting in more stable long-acting target proteins. At the same time, technicians have mastered a series of technologies such as separation and purification of PEG molecular modified proteins and quality detection.
Innovative Research And Development Platform For Macromolecular Biological Drugs
Yeast expression system is widely used in biomedical system, both the prokaryotic expression of the advantages of short fermentation cycle, low cost, at the same time have eukaryotic cells for the space of protein folding, glycosylation modification, such as ability, makes the protein to form natural stereo structure, to investigate the physiological activity of protein provides a powerful tool. Saccharomyces cerevisiae expression system and methanotrophic yeast expression system are commonly used. Methanol yeast expression system is the most widely used yeast expression system at present, compared with SACCHARomyces cerevisiae system, the expression level is higher and can be used for high density cell culture. At present, methanolyeasts mainly include Hansenula, Pichia, Torulopsis, etc. Pichia is a relatively perfect methanoltrophic yeast expression system developed in recent years, which is widely used to express exogenous proteins. The company has rich host cell resources and carrier selection experience, which can effectively increase protein expression while avoiding the generation of impurities and degradation of target protein. Our r & D personnel have rich experience in pichia pastoris expression system, which can maximize the expression potential of yeast strains and improve the success rate and expression level. At the same time, the target product was obtained with high yield and purity.
Small Molecule Active Targeting Nano Delivery System Preparation Platform
We use chemical modification technology to modify protein drugs to solve the problems of short half-life and immunogenicity of large molecular protein drugs in blood, maintain the drug biological activity of protein, improve the half-life of protein, which is the development trend of biotechnology drugs in recent years. The company has mastered PEG (POLYEthyleneglycol) modification and aliphatic chain modification technology of protein polypeptide drugs to achieve the technical goal of long-term effect of drugs. PEG modifiers have the advantages of non-toxicity, good solubility, low immunogenicity and diversified modification methods, and are one of the few synthetic polymers approved by FDA that can be used for in vivo injection. The key core is that the company's PROTEIN PEG modification technology has the ability to achieve site-specific modifications, as opposed to random modifications currently available on the market, resulting in more stable long-acting target proteins. At the same time, technicians have mastered a series of technologies such as separation and purification of PEG molecular modified proteins and quality detection.